Chandra Bhagat Pharma Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 950,000 (48%) | — | ₹485 Cr |
| Retail | — | 950,000 (48%) | — | ₹485 Cr |
| Market Maker | — | 100,000 (5%) | — | ₹5 Cr |
| Σ Total | — | 2,000,000 (100%) | — | ₹10,200 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹102,000 |
| Retail (Max) | 13 | 26,000 | ₹1,326,000 |
| S-HNI (Min) | 14 | 28,000 | ₹1,428,000 |
| B-HNI (Min) | 67 | 134,000 | ₹6,834,000 |
Financial Statements Amount in Rs Cr
| Metric | 30-July-19 | 31-Mar-19 | 31-Mar-18 |
|---|---|---|---|
| Revenue | 3,345 | 10,672 | 9,773 |
| Profit After Tax | 25 | 63 | 103 |
| Total Assets | 8,594 | 8,286 | 5,806 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- To Meet Incremental Working Capital Requirements – 7.00
- Setting up Distribution and Warehousing Centre’s – 1.50
- General Corporate Purpose – 0.95
- To meet Public Issue Expenses – 0.75
Company Overview
Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.
The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.
The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.
Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.
Competitive Strengths
1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market